Subscribe

Audrey Andrews

Authored Articles

Can FDA Drug Approval Keep Pace with Translational Research?
Audrey Andrews
Economics & Value, Economics of Cancer Care
November 2013, Vol 4, No 9
Read Article
Health Disparities in Oncology: Western Europe Spends More, Achieves Better Patient Survival Outcomes than Eastern Europe
Audrey Andrews
Disparities in Oncology, Economics & Value, Economics of Cancer Care
November 2013, Vol 4, No 9
Read Article
Comparative Effectiveness Research Should Reap Benefits for Oncology Care
Audrey Andrews
Breast Cancer, Breast Cancer Symposium, Solid Tumors
October 2013, Vol 4, No 8
Read Article
Current Patterns and Costs of Treating Patients with Metastatic Breast Cancer
Audrey Andrews
Breast Cancer, Breast Cancer Symposium, Solid Tumors
October 2013, Vol 4, No 8
Read Article
For Oncologists, Some Food for Thought in the New Era of Healthcare Reform
Audrey Andrews
Breast Cancer, Breast Cancer Symposium, Solid Tumors
October 2013, Vol 4, No 8
Read Article
The State of Cancer Globally in 2013
Audrey Andrews
ESMO 2013 Conference, ESMO
October 2013, Vol 4, No 8
Read Article
Nearly 1 in 5 Patients with Cancer Reports Financial Distress
Audrey Andrews
Economics & Value, Economics of Cancer Care
July 2013, Vol 4, No 6
Read Article
Immunotherapies Take Center Stage in Melanoma
Audrey Andrews
ASCO Annual Meeting, ASCO
June 2013, Vol 4, No 5
Read Article
NCCN Updates Its Clinical Practice Guidelines
Audrey Andrews
NCCN Annual Conference
May 2013, Vol 4, No 4
Read Article
The Changing Oncology Landscape: Evolution or Revolution?
Audrey Andrews
NCCN Annual Conference
May 2013, Vol 4, No 4
Read Article
New Meta-Analysis: Complete Response to Neoadjuvant Therapy in Breast Cancer Predictor of Long-Term Benefit
Audrey Andrews
Clinical Research, Personalized Medicine
March 2013, Highlights
Read Article
Letrozole Superior to Tamoxifen for a Subtype of Breast Cancer
Audrey Andrews
Hormone Therapy, Personalized Medicine
March 2013, Highlights
Read Article
Sentinel Node Surgery Correctly Stages Lymph Nodes Following Neoadjuvant Chemotherapy
Audrey Andrews
Sentinel Node Management, Personalized Medicine
March 2013, Highlights
Read Article
Breast Cancer Index Predicts Late Recurrences in Patients with ER-Positive Breast Cancer
Audrey Andrews
Prognostic Tests, Personalized Medicine
March 2013, Highlights
Read Article
Overall Survival Trend Seen with Eribulin versus Capecitabine
Audrey Andrews
March 2013, Highlights
Read Article
Risk of Leukemia after Chemotherapy Small, but Real
Audrey Andrews
Chemotherapy, Personalized Medicine
March 2013, Highlights
Read Article
Dose-Dense Chemotherapy in Breast Cancer
Audrey Andrews
Chemotherapy, Personalized Medicine
March 2013, Highlights
Read Article
Targetable Pathways Revealed for Triple-Negative Breast Cancer
Audrey Andrews
Breast Cancer, Solid Tumors
March 2013, Highlights
Read Article
ATLAS: Ten Years of Tamoxifen Superior to 5 Years
Audrey Andrews
Hormone Therapy, Personalized Medicine
March 2013, Highlights
Read Article
In First-Line Metastatic CRC, Outcomes Comparable for Panitumumab and Bevacizumab
Audrey Andrews
GI Cancers Symposium
February 2013, Vol 4, No 2
Read Article
ATLAS: Ten Years of Tamoxifen Superior to 5 Years
Audrey Andrews
Breast Cancer
January 2013, Vol 4, No 1
Read Article
Breast-Conserving Surgery Underutilized
Audrey Andrews
Breast Cancer
January 2013, Vol 4, No 1
Read Article
Ibrutinib: It’s Not Just for Leukemia
Audrey Andrews
ASH 2013 Annual Meeting
January 2013, Vol 4, No 1
Read Article
No Increase in Leukemia or MDS with Adjuvant Chemotherapy for Breast Cancer
Audrey Andrews
Breast Cancer Symposium
November 2012, Vol 3, No 8
Read Article
Oncotype DX Score Predicts Residual Disease after Chemotherapy
Audrey Andrews
Breast Cancer Symposium
November 2012, Vol 3, No 8
Read Article
Crizotinib Superior to Chemotherapy, Extends Median Survival in First Head-to-Head Trial
Audrey Andrews
ESMO 2012 Conference, ESMO
October 2012, Vol 3, No 7
Read Article
Is Pemetrexed/Platinum Therapy Cost-Effective in NSCLC?
Audrey Andrews
AMCP Annual Meeting
July 2012, Vol 3, No 5
Read Article
Patients Willing to Pay Out of Pocket for Genetic Testing to Assess Colorectal Cancer Risk
Audrey Andrews
ASCO Annual Meeting, ASCO
July 2012, Vol 3, No 5
Read Article
Can Drug Cost Drive Oral Medication Adherence Up?
Audrey Andrews
ASCO Annual Meeting, ASCO
July 2012, Vol 3, No 5
Read Article
Cancer and Corporate America: Business as Usual?
Audrey Andrews
NCCN Conference
June 2012, Vol 3, No 4
Read Article
BRAF and MEK Inhibitors Make News at ASCO
Audrey Andrews
ASCO Annual Meeting, ASCO
June 2012, Vol 3, No 4
Read Article
EMILIA: Trastuzumab Emtansine Prolongs Remission in Advanced Breast Cancer
Audrey Andrews
ASCO Annual Meeting, ASCO
June 2012, Vol 3, No 4
Read Article
Updated NCCN Practice Guidelines in Oncology Include 3 New Panels
Audrey Andrews
NCCN Conference
May 2012, Vol 3, No 3
Read Article
NCCN Clinical Practice Guidelines Update
Audrey Andrews
NCCN Conference
May 2012, Vol 3, No 3
Read Article
Optimal Care for Patients with Cancer: Who Decides?
Audrey Andrews
NCCN Conference
May 2012, Vol 3, No 3
Read Article
Predictive Biomarker for Bevacizumab May Be Emerging
Audrey Andrews
ESMO 2011 Conference, ESMO
December 2011, Vol 2, No 7
Read Article
5-Year Analysis of VISTA Confirms Survival Advantage with Bortezomib for Patients with Myeloma
Audrey Andrews
ASH 2013 Annual Meeting
December 2011, Vol 2, No 7
Read Article
Order of Initial Breast Cancer Treatment Does Not Affect Outcomes
Audrey Andrews
Breast Cancer Symposium
October 2011, Vol 2, No 6
Read Article
Occult Metastases Do Not Warrant Axillary Dissection in Breast Cancer
Audrey Andrews
Breast Cancer Symposium
October 2011, Vol 2, No 6
Read Article
Breast Cancer Treatment Still Under Par for Patients Covered by Medicaid
Audrey Andrews
Breast Cancer Symposium
October 2011, Vol 2, No 6
Read Article
Novel HDAC Inhibitor Improves Outcomes in Patients with Estrogen-Sensitive Breast Cancer
Audrey Andrews
October 2011, Vol 2, No 6
Read Article
The Road to Personalized Medicine Is Strewn with Obstacles
Audrey Andrews
ESMO, ESMO 2011 Conference
October 2011, Vol 2, No 6
Read Article
Prolonged Treatment with Imatinib for High-Risk GIST Increases Survival, Reduces Recurrence
Audrey Andrews
ASCO Annual Meeting
August 2011, Vol 2, No 5
Read Article
Bevacizumab Maintenance Reduces Disease Progression Risk in Ovarian Cancer
Audrey Andrews
ASCO Annual Meeting
August 2011, Vol 2, No 5
Read Article
Upper GI Cancers: Are We Getting Value for the Money?
Audrey Andrews
ASCO Annual Meeting
August 2011, Vol 2, No 5
Read Article

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.